ADVANCED (INOPERABLE) NON SMALL CELL LUNG CANCER
Clinical trials for ADVANCED (INOPERABLE) NON SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED (INOPERABLE) NON SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for ADVANCED (INOPERABLE) NON SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for lung cancer patients: experimental drug shows promise in early trial
Disease control CompletedThis study tested a new drug called AZD9291 in 603 people with advanced non-small cell lung cancer whose tumors had started growing again after previous targeted therapy. The main goals were to find the best dose, check for side effects, and see if the drug could shrink tumors. R…
Matched conditions: ADVANCED (INOPERABLE) NON SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 26, 2026 11:18 UTC
-
Lung cancer drug interaction study: does itraconazole boost AZD9291 levels?
Knowledge-focused CompletedThis study looked at how the antifungal drug itraconazole changes the amount of AZD9291 in the blood of people with a specific type of advanced lung cancer (EGFR mutation-positive NSCLC) that stopped responding to previous treatments. Thirty-nine adults took a single dose of AZD9…
Matched conditions: ADVANCED (INOPERABLE) NON SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated May 26, 2026 11:22 UTC